These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 25896376)

  • 1. Diagnosing the determinants of vaccine hesitancy in specific subgroups: The Guide to Tailoring Immunization Programmes (TIP).
    Butler R; MacDonald NE;
    Vaccine; 2015 Aug; 33(34):4176-9. PubMed ID: 25896376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to deal with vaccine hesitancy?
    Eskola J; Duclos P; Schuster M; MacDonald NE;
    Vaccine; 2015 Aug; 33(34):4215-7. PubMed ID: 25896378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of vaccine hesitancy: Rationale, remit and methods.
    Schuster M; Eskola J; Duclos P;
    Vaccine; 2015 Aug; 33(34):4157-60. PubMed ID: 25896380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine hesitancy: Definition, scope and determinants.
    MacDonald NE;
    Vaccine; 2015 Aug; 33(34):4161-4. PubMed ID: 25896383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The WHO Tailoring Immunization Programmes (TIP) approach: Review of implementation to date.
    Dubé E; Leask J; Wolff B; Hickler B; Balaban V; Hosein E; Habersaat K
    Vaccine; 2018 Mar; 36(11):1509-1515. PubMed ID: 29287678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring vaccine hesitancy: The development of a survey tool.
    Larson HJ; Jarrett C; Schulz WS; Chaudhuri M; Zhou Y; Dube E; Schuster M; MacDonald NE; Wilson R;
    Vaccine; 2015 Aug; 33(34):4165-75. PubMed ID: 25896384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailoring immunisation programmes: Using behavioural insights to identify barriers and enablers to childhood immunisations in a Jewish community in London, UK.
    Letley L; Rew V; Ahmed R; Habersaat KB; Paterson P; Chantler T; Saavedra-Campos M; Butler R
    Vaccine; 2018 Jul; 36(31):4687-4692. PubMed ID: 29945834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of vaccine hesitancy and immunization coverage rates in the European Union.
    Stoeckel F; Carter C; Lyons BA; Reifler J
    Vaccine; 2021 Jun; 39(29):3935-3939. PubMed ID: 34116875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017.
    Lane S; MacDonald NE; Marti M; Dumolard L
    Vaccine; 2018 Jun; 36(26):3861-3867. PubMed ID: 29605516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping vaccine hesitancy--country-specific characteristics of a global phenomenon.
    Dubé E; Gagnon D; Nickels E; Jeram S; Schuster M
    Vaccine; 2014 Nov; 32(49):6649-54. PubMed ID: 25280436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing vaccine hesitancy: The potential value of commercial and social marketing principles and practices.
    Nowak GJ; Gellin BG; MacDonald NE; Butler R;
    Vaccine; 2015 Aug; 33(34):4204-11. PubMed ID: 25900132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parental childhood vaccine hesitancy and predicting uptake of vaccinations: a systematic review.
    Obohwemu K; Christie-de Jong F; Ling J
    Prim Health Care Res Dev; 2022 Nov; 23():e68. PubMed ID: 36330835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012.
    Larson HJ; Jarrett C; Eckersberger E; Smith DM; Paterson P
    Vaccine; 2014 Apr; 32(19):2150-9. PubMed ID: 24598724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for addressing vaccine hesitancy - A systematic review.
    Jarrett C; Wilson R; O'Leary M; Eckersberger E; Larson HJ;
    Vaccine; 2015 Aug; 33(34):4180-90. PubMed ID: 25896377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies intended to address vaccine hesitancy: Review of published reviews.
    Dubé E; Gagnon D; MacDonald NE;
    Vaccine; 2015 Aug; 33(34):4191-203. PubMed ID: 25896385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing tailored interventions to address barriers to vaccination.
    Habersaat K; MacDonald NE; Dubé È
    Can Commun Dis Rep; 2021 Mar; 47(3):165-168. PubMed ID: 34012341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health communication and vaccine hesitancy.
    Goldstein S; MacDonald NE; Guirguis S;
    Vaccine; 2015 Aug; 33(34):4212-4. PubMed ID: 25896382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine hesitancy and reported non-vaccination in an Irish pediatric outpatient population.
    Whelan SO; Moriarty F; Lawlor L; Gorman KM; Beamish J
    Eur J Pediatr; 2021 Sep; 180(9):2839-2847. PubMed ID: 33774718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine hesitancy in Argentina: Validation of WHO scale for parents.
    Gentile A; Pacchiotti AC; Giglio N; Nolte MF; Talamona N; Rogers V; Berenstein A; Castellano VE
    Vaccine; 2021 Jul; 39(33):4611-4619. PubMed ID: 34238609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and implementation of tailored intervention to increase vaccine acceptance in a Somali community in Stockholm, Sweden - based on the Tailoring Immunization Programmes approach.
    Jama A; Appelqvist E; Kulane A; Karregård S; Rubin J; Nejat S; Habersaat KB; Jackson C; Butler R; Lindstrand A; Godoy-Ramirez K
    Public Health Pract (Oxf); 2022 Dec; 4():100305. PubMed ID: 36570400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.